DNA damage response deficiency signature predicts response to platinum-based therapy in ovarian cancer

L. A. Hill; J. M. Mulligan; S. Deharo; K. E. Keating; F. A. McDyer; T. S. Davison; C. Gourley; D. P. Harkin; R. D. Kennedy

DNA damage response deficiency signature predicts response to platinum-based therapy in ovarian cancer

L. A. Hill, J. M. Mulligan, S. Deharo, K. E. Keating, F. A. McDyer, T. S. Davison, C. Gourley, D. P. Harkin, R. D. Kennedy

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Pages (from-to)	S196-S196
Number of pages	1
Journal	European Journal of Cancer
Volume	49
Issue number	2
Publication status	Published - Sep 2013
Event	17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity - Amsterdam, Netherlands Duration: 27 Sep 2013 → 01 Oct 2013

Bibliographical note

17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity, Amsterdam, NETHERLANDS, SEP 27-OCT 01, 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{690f0887b85f4a36b21a385e9ad241f4,

title = "DNA damage response deficiency signature predicts response to platinum-based therapy in ovarian cancer",

author = "Hill, {L. A.} and Mulligan, {J. M.} and S. Deharo and Keating, {K. E.} and McDyer, {F. A.} and Davison, {T. S.} and C. Gourley and Harkin, {D. P.} and Kennedy, {R. D.}",

note = "17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity, Amsterdam, NETHERLANDS, SEP 27-OCT 01, 2013; 17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity ; Conference date: 27-09-2013 Through 01-10-2013",

year = "2013",

month = sep,

language = "English",

volume = "49",

pages = "S196--S196",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier",

number = "2",

}

DNA damage response deficiency signature predicts response to platinum-based therapy in ovarian cancer. / Hill, L. A.; Mulligan, J. M.; Deharo, S.; Keating, K. E.; McDyer, F. A.; Davison, T. S.; Gourley, C.; Harkin, D. P.; Kennedy, R. D.

In: European Journal of Cancer, Vol. 49, No. 2, 09.2013, p. S196-S196.

Research output: Contribution to journal › Meeting abstract › peer-review

TY - JOUR

T1 - DNA damage response deficiency signature predicts response to platinum-based therapy in ovarian cancer

AU - Hill, L. A.

AU - Mulligan, J. M.

AU - Deharo, S.

AU - Keating, K. E.

AU - McDyer, F. A.

AU - Davison, T. S.

AU - Gourley, C.

AU - Harkin, D. P.

AU - Kennedy, R. D.

N1 - 17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity, Amsterdam, NETHERLANDS, SEP 27-OCT 01, 2013

PY - 2013/9

Y1 - 2013/9

M3 - Meeting abstract

VL - 49

SP - S196-S196

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 2

T2 - 17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity

Y2 - 27 September 2013 through 1 October 2013

ER -